The Study
DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1
This study is like taking apart a car engine in a lab to see how one part (DDB1) helps another part (ChREBPα) make more grease when you feed the car sugar. It shows how the parts connect, but it doesn't prove that the same thing happens in real cars (humans) or that fixing this part will stop grease buildup in all cars.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
When you eat a lot of fructose (like in soda), your liver makes a protein called ChREBPα that tells your body to turn sugar into fat. A helper protein called DDB1 protects ChREBPα from being broken down, so more fat builds up.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 515 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — reducing liver fat by 30–50% in mice suggests this pathway is a major driver of sugar-induced fatty liver, a common human health problem.
- 2DDB1 deletion cut liver fat by 50%; blocking CRY1 degradation (with a mutant) cut liver fat by 30%; fructose made ChREBPα last 2.5x longer (2h → 5h).
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Metabolism: clinical and experimental
Year
2020
Authors
X. Tong, Deqiang Zhang, Omar Shabandri, Joon Oh, Ethan Jin, K. Stamper, Meichan Yang, Zifeng Zhao, L. Yin
Related Content
Claims (6)
When people consume too much fructose from food, the liver converts it into fats called triglycerides and remnant lipoproteins, which lead to an increase in visceral fat.
In mouse liver cells, fructose reduces the tagging of ChREBPα for destruction, resulting in the protein lasting longer before being broken down by the proteasome.
In mouse liver cells, the protein CRY1 triggers the breakdown of ChREBPα, and reducing CRY1 levels results in higher amounts of ChREBPα.
In mice consuming a high-fructose diet, removing the DDB1 gene from liver cells reduces the stability of the ChREBPα protein, lowers the levels of key fat-producing enzymes, and decreases liver fat accumulation by about 50%.
In mouse liver cells, fructose causes a sixfold increase in the binding between DDB1 and ChREBPα proteins compared to glucose, and this binding depends on the C-terminal regions of both proteins, resulting in a stable molecular complex involving ChREBPα.
In mice consuming a high-fructose diet, the degradation of the CRY1 protein enables increased levels of ChREBPα and higher liver triglycerides; preventing CRY1 degradation reduces both ChREBPα and liver triglycerides by about 30%.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.